Login

Diversey IPO Preview with CEO Phil Wieland | Phil Wieland - CEO of Diversey Holdings 00:10:00

Share On Facebook Share On Twitter

Phil Wieland is the CEO of Diversey Holdings

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:00:00
Onconova Therapeutics featured on Worldwide Business - Dr. Steven Fruchtman, CEO, Onconova Therapeutics Inc
00:10:00
Rabobank's Robust Financial Performance and Strategic Initiatives | Bas Brouwers, CFO, Rabobank.
00:10:00
How Siav Spa Revolutionized Software Development with Oracle’s Cloud at Customer: Insights from CEO Nicola Voltan | Nicola Voltan, CEO, Siav Spa.
00:10:00
Transforming Aberdeen: CEO Stephen Byrd's Optimism Amidst Outflows|Stephen Bird,CEO,Abrdn plc
00:10:00
investments in SaaS and infrastructure software startups|Carmen Yuen,General Partner,Vertex Ventures
00:10:00
Entrevista com Salesio Nuhs, CEO da Taurus, em um episódio de "Entre Reis & CEOs", discutindo análise fundamentalista da ENGIE Brasil Energia S/A (EGIE3).
00:10:00
Fiji's Alkaline Gold Deposits: Potential for Major Discoveries
00:10:00
Lights, Camera, Action! Exploring the Intersection of Finance and Film with Alex Humphreys
00:10:00
Unlocking Anticipatory CX: Strategies for Enhanced Customer Engagement | Dudley Slater , Chairman at Fusion Connect Inc
00:10:00
Specializes in game developers|Ed Fries,General Partner,1Up Ventures
00:10:00
Tristan Zajonc: From Harvard PhD to Serial Entrepreneur - CEO of Continual Ltd. | Tristan Zajonc, CEO , Continual Ltd.
00:10:00
Core Laboratories CEO Larry Bruno shares his outlook for the oil and gas industry | Lawrence Bruno, CEO, Core Laboratories NVCLB:NYQ

© 2017 - Neuhu+